Rocket


Overview
Financials
News + Filings

 
 

Applied Therapeutics Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues114
            Revenue growth209.8% 
Cost of goods sold144
Gross profit-2-1
            Gross margin-17.8%-15.7%
General and administrative21
EBIT-14-4
            EBIT margin-117.8%-115.7%
Pre-tax income-17-4
Income taxes00
            Tax rate0.0%0.0%
Net income-17-4
            Net margin-144.0%-115.6%
 
Diluted EPS($166.47)($43.76)
Shares outstanding (diluted)00
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy